Head-to-head · WeighScore
Candor Rx vs Teleios Health
The verdict
Candor Rx takes it — 74.8/100 to 60.2/100.
Candor Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Candor Rx (candorrx.com) is a GLP-1 telehealth service offering compounded semaglutide and tirzepatide with flat, dose-independent pricing marketed as '$95/month, any dose, forever.' Semaglutide starts as…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Candor Rx | Teleios Health |
|---|---|---|
| WeighScore | 74.8/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #61 | #328 |
| Semaglutide | $99/mo (all doses, compounded) | $99/mo (starting dose, compounded) |
| Tirzepatide | $149/mo (all doses, compounded) | $139/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #61 · C
Strengths
- Flat, dose-independent pricing marketed as '$95/month, any dose, forever' — no upcharge as your dose increases
- Low starting prices: compounded semaglutide as low as $99/mo and tirzepatide as low as $149/mo
- Medication ships in about 48 hours and you can cancel anytime
- Simple, transparent GLP-1 focus with pricing shown up front before signup
Where it loses points
- Prescribing medical group and compounding pharmacy are not named on the site
- States of operation are not published; confirm eligibility during intake
- No LegitScript certification is displayed
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #328 · C
Strengths
- Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
- Compounded tirzepatide from a competitive $139/mo floor
- Markets physician (MD/DO) prescribing rather than an NP-only model
- Clean meta-tag and SEO implementation
Where it loses points
- Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
- No named medical director, physician, or corporate entity disclosed
- Year founded unknown — a newer floor-price entrant warranting extra scrutiny
- No LegitScript, NABP, or SOC 2 trust signal found
- Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.